army to test aids vaccine early in 1994

CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update Army to Test AIDS Vaccine Early in 1994
August 20, 1993

Washington Post (08/20/93) P. A20 With intense opposition from officials at the National Institutes of Health, large-scale testing of an AIDS vaccine will begin early in 1994. The vaccine, called VaxSyn, is a product of MicroGeneSys, a Connecticut pharmaceutical company. Scientists at NIH studied the results of previous, smaller studies and concluded that the vaccine did not demonstrate enough promise to warrant a large-scale trial. Officials at the Walter Reed Army Institute of Research, however, disagree, claiming that they had encouraging results from the earlier tests. MicroGeneSys lobbied Congress and was rewarded with a $20 million appropriation to conduct the trials, which may take up to four years and will directly study 5,000 to 10,002 HIV-infected patients.

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Positive living Lawyer: NY man at center of HIV scare not positive Zimbabwe activist: Prisoners denied AIDS drugs Youth organizations form a pact for social transformation in the AIDS response CountyCare Offers Historic Opportunity to Improve Care for People with HIV International AIDS Advocates Demand China Give $1 Billion to Global Fund Kingdom of Bahrain and UNAIDS commit to intensify cooperation CANADA: Celibate Homosexual Men Now Allowed to Donate Blood in Canada AFRICA: UN: AIDS Deaths Down, Treatment Up in Africa MICHIGAN: STD Fee for Jackson County Walk-In Clinic Takes Effect June 3 UN: AIDS Deaths Down, Treatment Up in Africa Nairobi Solidarity Rally May 10 Proclaims: “No Retreat on AIDS – Treatment for All”Screening Events Promote Hepatitis Testing and Prevention during National Hepatitis Awareness Month AHF: Global AIDS Patients, Doctors Lobby Congress on PEPFAR Reauth International AIDS Advocates Demand China Give $1 Billion to Global Fund Zimbabwe activist: Prisoners denied AIDS drugs Youth organizations form a pact for social transformation in the AIDS response AFRICA: UN: AIDS Deaths Down, Treatment Up in Africa Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog Global HIV/AIDS leaders meet in SF, Oakland
Copyright © 1993 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles. Information in this article was accurate in August 20, 1993. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.